Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Substance Withdrawal Syndrome × nilotinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia, Myeloid, Chronic-Phase 3 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Substance Withdrawal Syndrome 1 Sarcoma 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Necrosis 1 Myeloproliferative Disorders 1 Leukemia 1 Genital Neoplasms, Female 1 Colorectal Neoplasms 1 Appendiceal Neoplasms 1

Interventions

nilotinib 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04147533 2024-11-26

HALF

Masaryk University

Phase 2 Active not recruiting

Other hematologic neoplasm

Substance Withdrawal Syndrome, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon ⚡